Major Depression Clinical Trials

Find Major Depression Clinical Trials Near You

Effect of Suicidality in Major Depressive Disorder During Social Cognition

Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Other
Study Type: Observational
SUMMARY

Major Depressive Disorder (MDD) is a very common illness that is usually treated with antidepressant medication. Depression can be caused by many things such as childhood experiences, genetics, and changes in the way the body and brain function. It is most likely caused by a combination of several of these factors. The prevalence of suicide attempt in Major Depressive Disorder (MDD) is about 20%. Risk for suicide attempt can be increased by many things such as negative life events, genetics, and changes in the way the body and brain function. It is most likely caused by a combination of several of these factors. In this study, the investigators will be collecting detailed information about participants' psychiatric history and depression symptoms, as well as brain scans. The goal is to use this information to help us determine what predicts suicide attempt history.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
View:

⁃ Depressed Participants:

• Between the ages of 18 and 65 years old.

• Capable of giving voluntary and informed consent.

• Fluent in English.

• Meet DSM-5 criteria for single or recurrent Major Depressive Disorder (current major depressive episode), confirmed via the Mini-International Neuropsychiatric Interview (MINI 6.086).

• Moderate to severe depression severity, defined as a 17-item Hamilton Depression Rating Scale87 score ≥ 17.

• Have had no initiation or dose change in any psychotropic medication in the four weeks prior to screening, as confirmed by the Antidepressant Treatment History Form (ATHF88).

• If participating in psychotherapy, must have been in stable treatment for at least 3 months prior to entry into the study, with no anticipation of change in the frequency of therapeutic sessions, or the therapeutic focus over the duration of the study.

• Can adhere to the study schedule.

• Either a history of or no lifetime history of suicide attempt, confirmed via the Mini-International Neuropsychiatric Interview (MINI 6.086).

⁃ Nondepressed Participants:

• Between the ages of 18 and 65 years old.

• Capable of giving voluntary and informed consent.

• Fluent in English.

• No current or lifetime history of psychiatric diagnoses or suicidality, confirmed via the MINI 6.086.

• Absent/non-clinical depression severity, defined as a 17-item Hamilton Depression Rating Scale87 \< 8.

• No history of antidepressant use, as measured by the ATHF88.

Locations
Other Locations
Canada
Unity Health Toronto
RECRUITING
Toronto
Contact Information
Primary
Katharine Dunlop, PhD
katharine.dunlop@unityhealth.to
416-864-6060
Time Frame
Start Date: 2022-09-01
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 150
Treatments
Healthy controls, or people who do not have depression.
People diagnosed with MDD and a history of suicide attempt
People diagnosed with MDD without a history of suicide attempt
Related Therapeutic Areas
Sponsors
Leads: Unity Health Toronto

This content was sourced from clinicaltrials.gov